C6-Luc Cells
General information
| Description | C6-Luc is a genetically modified derivative of the rat C6 glioma cell line, which was originally established from a N-nitrosomethylurea-induced glial brain tumour in a Wistar rat by Benda et al. (1968). The parental C6 line was stably transfected with a eukaryotic expression plasmid encoding luciferase under control of a constitutive promoter, followed by selection with hygromycin B to obtain stably expressing monoclonal populations. C6-Luc cells constitutively express luciferase and emit bioluminescent signal in the presence of a luciferin substrate, enabling real-time, non-invasive monitoring of tumour growth by bioluminescence imaging (BLI) in live animals. The line is used to establish orthotopic syngeneic glioma models in Wistar or Sprague-Dawley rats following intracranial stereotactic implantation, and in subcutaneous xenograft models. Applications include evaluation of anti-glioma therapies, drug penetration across the blood-brain barrier, and development of brain tumour imaging platforms. |
|---|---|
| Organism | Rat |
| Tissue | Brain |
| Disease | Rat malignant glioma |
| Applications | Orthotopic rat glioma model for bioluminescence imaging; preclinical evaluation of anti-glioma therapies; blood-brain barrier drug penetration studies; neuroscience and brain tumour research. |
| Synonyms | Luciferase Reporter C6 Cell Line |
Characteristics
| Age | Age unspecified |
|---|---|
| Gender | Male |
| Morphology | Polygonal / epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | C6-Luc (Cytion catalog number 305620) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 10116 |
| CellosaurusAccession | CVCL_E3GZ |
| GMO Status | GMO-S1: This cell line contains a stably integrated firefly luciferase reporter cassette (Luc2, codon-optimized) introduced via replication-incompetent lentiviral transduction. The resulting polyclonal cell population was maintained under puromycin selection (1–5 µg/mL). S1 containment is required. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Antigen expression | Luc2 (firefly, codon-optimized) |
|---|---|
| Tumorigenic | Yes; forms intracranial tumours in syngeneic Wistar/Sprague-Dawley rats |
| Products | Firefly luciferase (luc2, pGL4.50) |
Handling
| Culture Medium | Ham's F12, w: 2 mM L-Glutamine |
|---|---|
| Supplements | 10% Fetal Bovine Serum |
| Doubling time | 24-48 hours |
| Subculturing | Passage sub-confluent cultures (70–80%) at 1:3 to 1:6 using 0.25% Trypsin/EDTA. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305620-110526 | Certificate of Analysis | 24. Jun. 2026 | 305620 |